ClassID:

93255

C07C279/26 - CPC Classification

Classification description:

Derivatives of guanidine, i.e. compounds containing the group , the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups , X being a hetero atom, Y being any atom, e.g. acylguanidines; Y being a hetero atom X and Y being nitrogen atoms, i.e. biguanides

Sub-classes:
Recent Application in this class:
#1
20260078012
2026-03-19

NANOPARTICLE COMPOSITION AND METHOD OF USE AND MANUFACTURE

#2
20250382272
2025-12-18

CRYSTALLINE FORM OF INDAZIFLAM, METHODS FOR ITS PREPARATION AND USE THEREOF

#3
20250066289
2025-02-27

BIGUANIDE DERIVATIVE OF IBUPROFEN AND PROCESS OF PREPARATION THEREOF

#4
20240150279
2024-05-09

C PRIME AGENTS FOR TREATING METABOLIC DISORDERS

#5
20240067603
2024-02-29

CUBANYL BIGUANIDE COMPOUNDS

#6
20230234919
2023-07-27

SYNTHESIS METHOD AND APPLICATION OF METFORMIN HYDROCHLORIDE

#7
20220281810
2022-09-08

Therapeutics for central nervous system disorders

#8
20220250932
2022-08-11

METHOD OF TREATING CANCER WITH A METALLIC NANOPARTICLE COMPOSITION

#9
20220054364
2022-02-24

HIGHLY LOADED METAL OXIDE MATERIALS BY SELF-ASSEMBLY FOR EXTENDED BIOLOGICALLY ACTIVE MOLECULE RELEASE IN MEDICAL AND DENTAL APPLICATIONS

#10
20220000722
2022-01-06

Highly loaded metal oxide materials by self-assembly for extended biologically active molecule release in medical and dental applications

#11
20210380529
2021-12-09

PREPARATION OF METFORMIN HYDROCHLORIDE FREE FROM GENOTOXIC IMPURITY

#12
20210355074
2021-11-18

Cycloheptylamine derivatives as anti-diabetic agents

#13
20210347725
2021-11-11

Cycloheptylamine derivatives as anti-diabetic agents

#14
20210130182
2021-05-06

Therapeutic metallic nanoparticle composition and method of use and manufacture thereof

#15
20210040035
2021-02-11

Process for the preparation of metformin

#16
20200283378
2020-09-10

Therapeutics for central nervous system disorders

#17
20200277255
2020-09-03

Biguanide compound and use thereof

#18
20200222343
2020-07-16

Metformin amino acid compounds and methods of using the same

#19
20200199168
2020-06-25

Class A GPCR-binding compound modifier

#20
20200199067
2020-06-25

Hydrogen sulfide donor in organic salt form and preparation method therefor

#21
20200171158
2020-06-04

PRESERVED COMPOSITIONS CONTAINING HYALURONIC ACID OR A PHARMACEUTICALLY-ACCEPTABLE SALT THEREOF AND RELATED METHODS

#22
20200022992
2020-01-23

CONJUGATE COMPOUNDS OF URSODEOXYCHOLIC, BERBERINE OR L-CARNITINE, AND COMPOSITIONS AND METHODS THEREOF

#23
20190359561
2019-11-28

BASE GENERATOR, BASE-REACTIVE COMPOSITION CONTAINING SAID BASE GENERATOR, AND BASE GENERATION METHOD

#24
20190328685
2019-10-31

Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient

#25
20190315680
2019-10-17

Inhibitors of creatine transport and uses thereof

#26
20190298698
2019-10-03

Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function

#27
20190263825
2019-08-29

WATER SOLUBLE SALTS OF ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETIC COMPLICATIONS

#28
20190151205
2019-05-23

Highly loaded metal oxide materials by self-assembly for extended biologically active molecule release in medical and dental applications

#29
20190076534
2019-03-14

Preserved compositions containing hyaluronic acid or a pharmaceutically-acceptable salt thereof and related methods

#30
20190076380
2019-03-14

Biguanide compositions and methods of treating metabolic disorders

#31
20190055210
2019-02-21

Photocuring method, compound and composition used therein

#32
20190046480
2019-02-14

Methods of treating developmental disorders with biguanides

#33
20190040019
2019-02-07

Process for producing biguanidine salts and s-triazines

#34
20190002403
2019-01-03

Acid-resistant base and/or radical generator, and curable resin composition containing said base and/or radical generator

#35
20180303774
2018-10-25

Composition for treatment of inflammatory bowel disease and atopic dermatitis

#36
20180256520
2018-09-13

Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient

#37
20180093953
2018-04-05

Guanidine compounds and use thereof

#38
20180050001
2018-02-22

Methods of treating developmental disorders with biguanides

#39
20180044283
2018-02-15

Biguanide compound and use thereof

#40
20170362237
2017-12-21

WATER SOLUBLE SALTS OF ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETIC COMPLICATIONS

#41
20170333370
2017-11-23

Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing biguanide derivative compound as active ingredient

#42
20170327455
2017-11-16

Omefibrates for Treating Dyslipidemia and Cardiovascular Disease

#43
20170210704
2017-07-27

DEUTERO-PHENFORMIN DERIVATIVES

#44
20170196890
2017-07-13

TGR5 agonist complexes for treating diabetes and cancer

#45
20170165209
2017-06-15

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

#46
20170073331
2017-03-16

Guanidine compounds and use thereof

#47
20170050924
2017-02-23

Inhibitors of creatine transport and uses thereof

#48
20160340374
2016-11-24

Borate-based base generator, and base-reactive composition comprising such base generator

#49
20160317478
2016-11-03

Biguanide derivative, a preparation method thereof, and a pharmaceutical composition containing the biguanide derivative as an active ingredient

#50
20160272582
2016-09-22

Compositions and methods for the treatment of hyperglycemia and metabolic syndrome

#51
20160244405
2016-08-25

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HYPERGLYCEMIA AND METABOLIC SYNDROME

#52
20160136136
2016-05-19

Therapeutic approaches for treating Alzheimer disease and related disorders through a modulation of synapse function

#53
20160122292
2016-05-05

Base generator, base-reactive composition containing said base generator, and base generation method

#54
20160101112
2016-04-14

Pharmaceutical composition comprising N1-cyclic amine-N5-substituted biguanide derivatives as an ingredient for preventing or treating fibrosis

#55
20150376123
2015-12-31

Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient

#56
20150344402
2015-12-03

Omefibrates for Treating Dyslipidemia and Cardiovascular Disease

#57
20150342909
2015-12-03

Therapeutic compounds and methods

#58
20150313908
2015-11-05

Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders

#59
20150289510
2015-10-15

Herbicidal azines

#60
20150197475
2015-07-16

Tri-salt form of metformin

#61
20150196509
2015-07-16

Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk

#62
20150183728
2015-07-02

Compositions for the treatment of diabetes and pre-diabetes

#63
20150158832
2015-06-11

Compounds and methods of treating cancer

#64
20150051284
2015-02-19

Lipid-lowering antidiabetic agent

#65
20140364500
2014-12-11

URSOLIC ACID SALTS FOR TREATING DIABETES AND OBESITY

#66
20140357680
2014-12-04

Compositions for the treatment of diabetes and pre-diabetes

#67
20140341986
2014-11-20

Biguanide compositions and methods of treating metabolic disorders

#68
20140249221
2014-09-04

Tri-salt form of metformin

#69
20140228319
2014-08-14

WATER SOLUBLE SALTS OF ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETIC COMPLICATIONS

#70
20140107360
2014-04-17

Lipid-lowering antidiabetic agent

#71
20140024708
2014-01-23

URSOLIC ACID SALTS FOR TREATING DIABETES AND OBESITY

#72
20130281535
2013-10-24

Lipid-lowering antidiabetic agent

#73
20130095140
2013-04-18

Biguanide compositions and methods of treating metabolic disorders

#74
20120329834
2012-12-27

COMPOUNDS FOR THE TREATMENT OF MITOCHONDRIAL DISEASES

#75
20120309799
2012-12-06

Biguanide derivative, preparation method thereof, and pharmaceutical composition containing same as an active ingredient

#76
20120289485
2012-11-15

Metformin salts of salicylic acid and its congeners

#77
20120283299
2012-11-08

Biguanide derivative, a preparation method thereof and a pharmaceutical composition containing the biguanide derivative as an active ingredient

#78
20120277305
2012-11-01

Fatty acid guanidine and salicylate guanidine derivatives and their uses

#79
20120202756
2012-08-09

USE OF PRODRUGS TO AVOID GI MEDIATED ADVERSE EVENTS

#80
20120178813
2012-07-12

LIPID-LOWERING ANTIDIABETIC AGENT

#81
20120142920
2012-06-07

Triazine derivatives for use in the treatment of malaria

#82
20120136062
2012-05-31

Complex for treatment and/or prophylaxis of parasitic infections

#83
20120135952
2012-05-31

BUTYRIC ACID SALT OF N,N-DIMETHYL IMIDOCARBON IMIDIC DIAMIDE, METHOD OF PREPARING SAME, AND PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS CONTAINING SAME

#84
20120095254
2012-04-19

Method and apparatus for preparing a solution of shear sensitive material

#85
20120090250
2012-04-19

Retractable Enclosure

#86
20120024437
2012-02-02

Precursor of an explosive composition including at least one ionic liquid and a method of desensitizing an explosive composition

#87
20120010287
2012-01-12

N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

#88
20110269764
2011-11-03

THERAPEUTIC APPROACHES FOR TREATING ALZHEIMER DISEASE AND RELATED DISORDERS THROUGH A MODULATION OF SYNAPSE FUNCTION

#89
20110263901
2011-10-27

Process of Preparation of Proguanil

#90
20110207926
2011-08-25

NOVEL DIHYDROTRIAZINE DERIVATIVE

#91
20110171142
2011-07-14

Metformin glycinate salt for blood glucose control

#92
20110021634
2011-01-27

PROCESSES FOR PREPARING METFORMIN HYDROCHLORIDE

#93
20100249241
2010-09-30

N,N-dimethyl imidodicarbonimidic diamide dicarboxylate, method for producing the same and pharmaceutical compositions comprising the same

#94
20100105691
2010-04-29

Metformin folate and preparation of the same

#95
20100087544
2010-04-08

N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same

#96
20090287021
2009-11-19

Method and apparatus for preparing a solution of a shear sensitive material

#97
20090270653
2009-10-29

Process for producing 1-(3,4-dichlorobenzyl)-5-octylbiguanide or a salt thereof

#98
20090176773
2009-07-09

Non-Peptidic Inhibitors of AKAP/PKA Interaction

#99
20090123513
2009-05-14

Antimicrobial biguanide metal complexes

#100
20090005250
2009-01-01

Substituted 2,4-diamino-1,3,5-triazines, processes for their use as herbicides and crop growth regulators

#101
20080251169
2008-10-16

Ionic liquid and a method of synthesizing an ionic liquid

#102
20080176852
2008-07-24

Biguanide and dihydrotriazine derivatives

#103
20080015352
2008-01-17

Metal coordinated compositions

#104
20070293399
2007-12-20

SUBSTITUTED DIAMINO-1,3,5-TRIAZINES, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS HERBICIDES AND CROP GROWTH REGULATORS

#105
14938185
2016-06-21

Compositions and methods for the treatment of hyperglycemia and metabolic syndrome